Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dactylis glomerata allergen extract in pollen allergy
2010-023948-33Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Jul 2011
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of dactylis glomerata allergen extract in seasonal allergic rhinitis (SAR) and allergic rhinitis (AR) (3 arms), sponsored by LETI Pharma. Started Jul 2011; status: completed.
02
Drugs
dactylis glomerata allergen extract
03
Conditions
seasonal allergic rhinitis (SAR)allergic rhinitis (AR)
Beyond the preview
Go deeper on 2010-023948-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023948-33.